Concepedia

Shu Hou

SH

8

Publications

220

Citations

8

H-Index

1995

Active since

Affiliations

Anhui Medical University(Current)

Ministry of Education of the People's Republic of China

Beijing Shijitan Hospital

First Affiliated Hospital of Anhui Medical University

Shu Hou is an author at Anhui Medical University specializing in medicine, cell biology, and cancer research.

Top concepts

MedicineCell BiologyCancer ResearchHepatocellular CarcinomaPathologyHepatologyCell SignalingLiver PhysiologyCell DeathTumor Biology

Publications per year

1995–2023

8

Publications

8

Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways

Chong Zhang, Lili Li, Shu Hou et al. · Journal of Ethnopharmacology · 2021 · 49 citations

Hepatology, Medicine, Liver Physiology +12

DNA adducts caused by tamoxifen and toremifene in human microsomal system and lymphocytes <i>in vitro</i>

Kari Hemminki, Shu Hou · Carcinogenesis · 1995 · 38 citations

Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocellular carcinoma progression via miR-145/miR-21 mediated Smad3 phosphorylation

Chao Wu, Weiyang Chen, Meng Fang et al. · Journal of Ethnopharmacology · 2018 · 36 citations

Pathology, Compound Astragalus, Smad3 Phosphorylation +7

Amelioratory effects of astragaloside IV on hepatocarcinogenesis via Nrf2-mediated pSmad3C/3L transformation

Yong Fang Gong, Shu Hou, Jiacheng Xu et al. · Phytomedicine · 2023 · 25 citations · Full text

Proteomic changes of PC12 cells treated with proteasomal inhibitor PSI

Lei Zhang, Ming Chang, Hongjie Li et al. · Brain Research · 2007 · 21 citations

Proteomic Changes, Proteomic Technology, Protein Function +8

Rows per page

1–5 of 8